How Do I Add a New Peptide or Longevity Service Line to My Existing Clinic?

Direct answer

Treat a new peptide program as a new clinical service line — not as a new SKU. Before marketing or selling it, define the clinical purpose, responsible prescriber, patient-evaluation pathway, pharmacy/source, staffing model, documentation, monitoring, escalation, and implementation plan. Business opportunity can start the discussion; it should not replace clinical review.

Open the full explanation3 sections and primary sources

What is a practical sequence for adding a peptide or longevity line?

Define the business objective; identify the exact therapy (substance, formulation, route, source) rather than “we want to add peptides”; review the clinical and pharmacy framework (evidence, safety, sourcing, prescribing, patient selection); build the operating model (who does what, documentation, medication handling, monitoring, escalation); review clinic fit (space, training, workflow, AHCA/insurance impact); then prepare for launch.

MFMD’s service-line development role

MFMD helps an existing brick-and-mortar practice evaluate and structure the clinical side of the business opportunity — service concept review, clinical feasibility, governance structure, prescribing and staffing model, pharmacy/sourcing considerations, documentation and escalation framework, implementation planning, and physician review before launch. This is clinical service-line development and business development, not AHCA licensure consulting.

Owner takeaway

Build the service line before you build the marketing campaign. See Add a Service Line to start.

Primary sources

Review the cited source before applying the answer to a facility.

Separate the public question from the facility decision.

First confirm the facility type, AHCA or exemption status, payer model, licensed roster, and services. Then check the current official source and document who evaluates, prescribes, orders, administers, supervises, and escalates an exception.

MFMD can structure facility governance and present the proposed services and responsibilities to a physician. Clinical authority and acceptance remain with the reviewing physician.